Disease Management & Health Outcomes

, Volume 13, Issue 4, pp 281–285 | Cite as

Cost of Acute Myocardial Infarction in Hong Kong

  • Vivian W. Y. Lee
  • Wai Kwong Chan
  • Nelson L. C. Lam
  • Kenneth K. C. Lee
Original Research Article



Coronary artery disease (CAD) is the second highest cause of mortality in Hong Kong. The most significant manifestation is acute myocardial infarction (AMI). Both treatment and cardiac rehabilitation for AMI are costly. Knowledge of the cost of management of AMI is important for better planning for allocation of medical resources. The present study aims to evaluate and describe the cost of management of patients with explicit Q-wave AMI in a local public hospital in Hong Kong.


A retrospective study was performed of patients admitted to the United Christian Hospital in Hong Kong. The study cohort consisted of patients who were aged ≥18 years with a diagnosis of Q-wave AMI from 1 January 2000 to 31 December 2000 admitted to the coronary care unit. Cost items studied included hospital stay, outpatient clinic visits, diagnostic tests, medications, and percutaneous coronary interventions.


Ninety-five cases were evaluated. The average annual medical cost per patient for AMI management in the year 2000 was $US9323.4 ± 5792 ($US1 = HK$7.8). The total annual cost per patient increased with the complexity of the disease from $US7745 ± 6245 for non-fatal AMI without procedure to $US12 344 ± 3129 for non-fatal AMI with procedure. Based on the local epidemiological data, the prevalence rate of CAD is 2.2% and assuming 3% of patients with CAD may experience AMI with medical care, the estimated total cost of AMI management in Hong Kong was $US45 million per year or 0.5% of the 2000–2001 total healthcare expenditure.


This study provides information on the cost of AMI management in a local hospital of Hong Kong. Public awareness of CAD and the implementation of appropriate health measures should be reinforced.


Percutaneous Coronary Intervention Acute Myocardial Infarction Gross Domestic Product Acute Myocardial Infarction Healthcare Expenditure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



At the time of this study, Nelson L.C. Lam was a Master’s student in Pharmacoeconomics, School of Pharmacy, The Chinese University of Hong Kong.

This study was supported by the School of Pharmacy, The Chinese University of Hong Kong.


  1. 1.
    Mehta RH, Montoye CK, Gallogly MBA, et al., for the GAP Steering Committee of the American College of Cardiology. Improving quality care for acute myocardial infarction: the guidelines applied in practice (GAP) initiative. JAMA 2002; 287(10): 1269–76PubMedCrossRefGoogle Scholar
  2. 2.
    Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34: 890–911PubMedCrossRefGoogle Scholar
  3. 3.
    Madsen JK. Acute myocardial infarction. Circulation 1997; 96: 748–55PubMedCrossRefGoogle Scholar
  4. 4.
    Russell MW, Huse DM, Drown SMA, et al. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998; 81(9): 1110–5PubMedCrossRefGoogle Scholar
  5. 5.
    Woo J, Cockram C. Cost estimates for chronic diseases. Dis Manage Health Outcomes 2000; 8(1): 29–41CrossRefGoogle Scholar
  6. 6.
    List of charges. Hong Kong Government Gazette, Special Supplement No. 4 (13), 2003Google Scholar
  7. 7.
    The Hong Kong Hospital Authority. International comparison of population and health statistics [online]. Available from URL: [Accessed 2003 Oct 21]
  8. 8.
    Muramatsu N, Liang J. Hospital length of stay in the United States and Japan: a case study of myocardial infarction patients. Int J Health Serv 1999; 29(1): 189–209PubMedCrossRefGoogle Scholar
  9. 9.
    Matsui K, Polanczyk CA, Gaspoz JM, et al. Management of patients with acute myocardial infarction at five academic medical centers: clinical characteristics, resource utilization, and outcome. J Investig Med 1999; 47(3): 134–40PubMedGoogle Scholar
  10. 10.
    Gatin A, Budlot A, Bismuth MJ, et al. Medico-economic impact of the Program of Medicalization of the information system on hospital stay for myocardial infarction: influence of the quality of data collection and hospitalization length. Ann Cardiol Angeiol (Paris) 2001; 50(4): 189–96CrossRefGoogle Scholar
  11. 11.
    Newby KL, Eisenstein EL, Califf RM, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med 2000; 342(11): 749–55PubMedCrossRefGoogle Scholar
  12. 12.
    Koenig C, Stevermer J. Is a 3-day hospitalization cost-effective for patients after uncomplicated acute myocardial infarction (AMI)? J Fam Pract 2000; 49(6): 574PubMedGoogle Scholar
  13. 13.
    Antman EM, Kuntz KM. The length of the hospital stay after myocardial infarction. N Engl J Med 2000; 342(11): 808–10PubMedCrossRefGoogle Scholar
  14. 14.
    Schultz MA, van Servellen G, Chang BL, et al. The relationship of hospital structural and financial characteristics to mortality and length of stay in acute myocardial infarction patients. Outcomes Manag Nurs Pract 1998; 2(3): 130–6PubMedGoogle Scholar
  15. 15.
    Zethraeus N, Molin T, Henriksson P, et al. Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med 1999; 246(2): 151–9PubMedCrossRefGoogle Scholar
  16. 16.
    O’Brien JA, Caro I, Getsios D, et al. Diabetes in Canada: direct medical costs of major macrovascular complications. Value Health 2001; 4(3): 258–65PubMedCrossRefGoogle Scholar
  17. 17.
    Laffel GL, Fineberg HV, Braunwald E. A cost-effectiveness model for coronary thrombolysis/reperfusion therapy. J Am Coll Cardiol 1987; 10: 79B–90BPubMedCrossRefGoogle Scholar
  18. 18.
    Smith TL, Melfi CA, Kesterson JA, et al. Direct medical charges associated with myocardial infarction in patients with and without diabetes. Med Care 1999; 37(4): AS4–AS11PubMedCrossRefGoogle Scholar
  19. 19.
    Schellevis F, van der Velden J, van der Lisdonk E, et al. Comorbidity of chronic diseases in general practice. J Clin Epidemiol 1993; 46: 469–73PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Vivian W. Y. Lee
    • 1
  • Wai Kwong Chan
    • 2
  • Nelson L. C. Lam
    • 1
  • Kenneth K. C. Lee
    • 1
  1. 1.School of Pharmacy, Faculty of MedicineThe Chinese University of Hong KongShatinHong Kong
  2. 2.Division of Cardiology, Department of Medicine & GeriatricsUnited Christian HospitalHong Kong

Personalised recommendations